We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » REIMPORTATION DOMINATES McCLELLAN NOMINATION HEARING
FDA Commissioner Mark McClellan was peppered with questions about reimportation of Rx drugs and congressional oversight during what might have been a tougher-than-expected confirmation hearing yesterday.